Evidence map›Paper›PMID 30039351›Full record

ArticleJournal of physiology and biochemistry2018

Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food.

Christian Carpéné, Jean Galitzky, Chloé Belles, Alexia Zakaroff-Girard

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christian CarpénéINSERM U 1048 équipe 1, Institut des Maladies Métaboliques et Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM U1048), Université Paul Sabatier (I2MC-UPS), I2MC, Bât. L4, CHU Rangueil, BP 84225, 31432, Toulouse CEDEX 4, France. christian.carpene@inserm.fr.ORCID http://orcid.org/0000-0001-7765-6647
Jean GalitzkyINSERM U 1048 équipe 1, Institut des Maladies Métaboliques et Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM U1048), Université Paul Sabatier (I2MC-UPS), I2MC, Bât. L4, CHU Rangueil, BP 84225, 31432, Toulouse CEDEX 4, France.
Chloé BellesDIVA Expertise, Centre Pierre Potier, Toulouse, France.
Alexia Zakaroff-GirardINSERM U 1048 équipe 1, Institut des Maladies Métaboliques et Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM U1048), Université Paul Sabatier (I2MC-UPS), I2MC, Bât. L4, CHU Rangueil, BP 84225, 31432, Toulouse CEDEX 4, France.
Université Toulouse III - Paul Sabatier · FR

Funding

INSERM recurrent endowment N/A
6 · The paper itself

Abstract

Tyramine is found in foodstuffs, the richest being cheeses, sausages, and wines. Tyramine has been recognized to release catecholamines from nerve endings and to trigger hypertensive reaction. Thereby, tyramine-free diet is recommended for depressed patients treated with irreversible inhibitors of monoamine oxidases (MAO) to limit the risk of hypertension. Tyramine is a substrate of amine oxidases and also an agonist at trace amine-associated receptors. Our aim was to characterize the dose-dependent effects of tyramine on human adipocyte metabolic functions. Lipolytic activity was determined in adipocytes from human subcutaneous abdominal adipose tissue. Glycerol release was increased by a fourfold factor with classical lipolytic agents (1 μM isoprenaline, 1 mM isobutylmethylxanthine) while the amine was ineffective from 0.01 to 100 μM and hardly stimulatory at 1 mM. Tyramine exhibited a partial antilipolytic effect at 100 μM and 1 mM, which was similar to that of insulin but weaker than that obtained with agonists at purinergic A1 receptors, α

Indexed as

LipolysisAdenylate Cyclase ToxinAdrenergic alpha-2 Receptor AgonistsAdrenergic beta-AgonistsAdrenergic Uptake InhibitorsAdultCells, CulturedEnzyme InhibitorsFemaleGlycerolHumansHydrogen PeroxideHypoglycemic AgentsInsulinKineticsMonoamine OxidaseAdenylate Cyclase ToxinAdrenergic alpha-2 Receptor AgonistsAdrenergic beta-AgonistsAdrenergic Uptake InhibitorsEnzyme InhibitorsGlycerolHydrogen PeroxideHypoglycemic AgentsInsulinMonoamine OxidaseMonoamine Oxidase InhibitorsPhosphodiesterase InhibitorsProtein Tyrosine PhosphatasesTyramineAdipocyteAntilipolysisHydrogen peroxideLipolysisMonoamine oxidaseTrace amines

Identifiers

PMID30039351
OpenAlexW2884749869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.